We are live on ! Find out more
JY

Jeff Yass Susquehanna International Group

AUM $1.28T
1-Year Est. Return 58.89%
 

Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.

This Fund
S&P 500
This Quarter Est. Return
+5.22%
1 Year Est. Return
+58.89%
3 Year Est. Return
+161.44%
5 Year Est. Return
+153.95%
10 Year Est. Return
+545.54%
AUM
$663B
AUM Growth
+$90.2B
Cap. Flow
+$61.2B
Cap. Flow %
9.24%
Top 10 Hldgs %
28.05%
Holding
13,659
New
1,862
Increased
5,386
Reduced
4,790
Closed
1,590

Top Buys

Rank Stock Value
1
QQQ icon
Invesco QQQ Trust
QQQ
+$1.41B
2
AAPL icon
Apple
AAPL
+$949M
3
IWM icon
iShares Russell 2000 ETF
IWM
+$788M
4
MSFT icon
Microsoft
MSFT
+$654M
5
AVGO icon
Broadcom
AVGO
+$568M

Sector Composition

Rank Sector Weight
1 Technology 1.97%
2 Financials 0.89%
3 Consumer Discretionary 0.83%
4 Healthcare 0.75%
5 Communication Services 0.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CLSD
11976
CALL
DELISTED
Clearside Biomedical
CLSD
$11.5K ﹤0.01%
807
-1,233
-60% -$20.3K
TRIB
11977
Trinity Biotech
TRIB
$7.8M
$11K ﹤0.01%
+416
New +$16.7K
CNTX icon
11978
Context Therapeutics
CNTX
$38.9M
$10.7K ﹤0.01%
10,185
-44,026
-81% -$76.2K
ADAP
11979
CALL
DELISTED
Adaptimmune Therapeutics
ADAP
$10.5K ﹤0.01%
19,500
-13,200
-40% -$9.62K
CLSKW
11980
CleanSpark Inc Warrant
CLSKW
$255K
$10.4K ﹤0.01%
+14,474
New +$11.9K
HYPD
11981
Hyperion DeFi Inc
HYPD
$52.7M
$10.4K ﹤0.01%
891
+517
+138% +$12.5K
ACET icon
11982
PUT
Adicet Bio
ACET
$83.8M
$10.2K ﹤0.01%
+663
New +$12.5K
CBIO
11983
Crescent Biopharma
CBIO
$669M
$10.2K ﹤0.01%
+408
New +$11.1K
SEGG
11984
Sports Entertainment Gaming Global Corp
SEGG
$8.96M
$9.79K ﹤0.01%
+289
New +$8.12K
CBAT icon
11985
CBAK Energy Technology Ltd
CBAT
$82.4M
$9.46K ﹤0.01%
10,067
-32,138
-76% -$32.1K
ERNA icon
11986
Eterna Therapeutics
ERNA
$5.7M
$9.16K ﹤0.01%
+83
New +$22.5K
SENS icon
11987
CALL
Senseonics Holdings Inc
SENS
$494M
$9K ﹤0.01%
865
+90
+12% +$643
BMRA icon
11988
Biomerica
BMRA
$5.22M
$8.83K ﹤0.01%
3,678
-633
-15% -$1.67K
AMRN
11989
PUT
Amarin Corp
AMRN
$304M
$8.77K ﹤0.01%
895
-995
-53% -$10.7K
PRPL icon
11990
CALL
Purple Innovation
PRPL
$20.6M
$8.66K ﹤0.01%
444
-288
-39% -$6.52K
LCTX icon
11991
CALL
Lineage Cell Therapeutics
LCTX
$283M
$8.55K ﹤0.01%
+17,100
New +$12.6K
LXRX icon
11992
PUT
Lexicon Pharmaceuticals
LXRX
$1.03B
$7.99K ﹤0.01%
+10,800
New +$13K
FOXO
11993
DELISTED
FOXO TECHNOLOGIES INC A
FOXO
$7.93K ﹤0.01%
1,368
-3,855
-74% -$27.7K
BCAB icon
11994
PUT
BioAtla
BCAB
$5.2M
$7.79K ﹤0.01%
+264
New +$22.2K
AIM
11995
AIM ImmunoTech
AIM
$7.61M
$7.53K ﹤0.01%
+381
New +$8.88K
AIIO
11996
Robo.ai Inc
AIIO
$433M
$7.32K ﹤0.01%
+521
New +$10.3K
NWTG
11997
Newton Golf Co
NWTG
$6.67M
$6.91K ﹤0.01%
+549
New +$26.7K
VNRX icon
11998
VolitionRx Ltd
VNRX
$4.63M
$6.79K ﹤0.01%
566
-2,265
-80% -$30.4K
GORO icon
11999
CALL
Goldgroup Mining
GORO
$268M
$6.46K ﹤0.01%
+28,100
New +$6.41K
ONCO icon
12000
Onconetix
ONCO
$2.53M
$6.46K ﹤0.01%
+2
New +$20.2K

Similar funds

Jeff Yass's Q4 2024 Portfolio in Review

As of Q4 2024, Jeff Yass held 13,659 positions worth $663B, up 16% from $572B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Jeff Yass deployed $61.2B of net new capital in Q4 2024, opening 1,862 new positions and adding to 5,386 existing holdings. Its largest new stake was State Street SPDR S&P 400 Mid Cap Value ETF: 1,000,000 shares worth $80.2M.

By sector, the portfolio is most concentrated in Technology at 2% of assets, up from 1.8% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was iShares 20+ Year Treasury Bond ETF, an estimated $1.26B trimmed.

  • Jeff Yass's largest Q4 2024 buy was State Street SPDR S&P 400 Mid Cap Value ETF: 1,000,000 shares worth $80.2M.
  • Jeff Yass added most to Invesco QQQ Trust in Q4 2024, an estimated $1.41B increase.
  • Jeff Yass's biggest Q4 2024 reduction was iShares 20+ Year Treasury Bond ETF, cutting an estimated $1.26B.
  • Jeff Yass fully exited NextEra Energy 7.299% Corporate Units in Q4 2024, selling an estimated $112M.
  • Jeff Yass's ten largest holdings make up 28% of its $663B portfolio in Q4 2024.
  • Jeff Yass opened 1,862 new positions and closed 1,590 in Q4 2024.
  • Jeff Yass's portfolio value rose 16% quarter-over-quarter to $663B.

Based on Susquehanna International Group's 13F filing for Q4 2024, filed 14 Feb 2025.